• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidine carboxylic acids and derivatives Pyrrolidine carboxylic acids

tert-butyl 3-chloropyrrolidine-1-carboxylate (CAS No. 1289386-88-4): A Key Intermediate in Modern Pharmaceutical Synthesis

tert-butyl 3-chloropyrrolidine-1-carboxylate, identified by its CAS number 1289386-88-4, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry. This compound serves as a crucial intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and cardiovascular disorders. Its unique structural features, including a pyrrolidine core and a chloro-substituted side chain, make it an invaluable building block for medicinal chemists.

The< strong>pyrrolidine ring in tert-butyl 3-chloropyrrolidine-1-carboxylate is a privileged scaffold that is frequently encountered in drug discovery due to its ability to mimic the bioactive conformation of natural products. This structural motif is known to interact favorably with biological targets, such as enzymes and receptors, thereby enhancing the pharmacological activity of the final drug candidates. The presence of a< strong>chloro substituent at the 3-position further enhances the reactivity of this compound, making it an excellent candidate for further functionalization through nucleophilic substitution reactions.

In recent years, there has been a surge in research focused on developing novel treatments for neurological disorders. tert-butyl 3-chloropyrrolidine-1-carboxylate has emerged as a key intermediate in the synthesis of small-molecule inhibitors targeting neurodegenerative diseases such as Alzheimer's and Parkinson's. Studies have demonstrated that derivatives of this compound can modulate the activity of key enzymes involved in these pathologies, offering promising leads for future drug development. For instance, researchers have reported the synthesis of analogs that exhibit potent inhibitory effects on acetylcholinesterase, a enzyme critical in the management of Alzheimer's disease.

The< strong> tert-butyl group attached to the carboxylate moiety in tert-butyl 3-chloropyrrolidine-1-carboxylate provides stability to the molecule while also facilitating further derivatization. This feature is particularly useful in multi-step synthetic routes where protecting groups are required to prevent unwanted side reactions. The carboxylate group, on the other hand, serves as a versatile handle for coupling reactions, allowing for the attachment of various pharmacophores through amide bond formation.

The pharmaceutical industry has increasingly recognized the importance of high-quality intermediates like tert-butyl 3-chloropyrrolidine-1-carboxylate. The demand for such compounds has been driven by the need for more efficient and scalable synthetic pathways to produce novel therapeutics. Manufacturers specializing in fine chemicals have invested heavily in optimizing production processes to ensure high purity and yield, meeting the stringent requirements of pharmaceutical companies.

Recent advancements in computational chemistry have also played a pivotal role in leveraging< strong>tert-butyl 3-chloropyrrolidine-1-carboxylate. Molecular modeling studies have been conducted to predict how different derivatives might interact with biological targets based on the structure of this intermediate. These simulations have guided experimental efforts, significantly reducing the time and cost associated with hit identification and lead optimization.

The versatility of tert-butyl 3-chloropyrrolidine-1-carboxylate extends beyond its applications in neurological drug discovery. Researchers have explored its utility in developing treatments for cardiovascular diseases, where it has been used to synthesize compounds that modulate cholesterol levels and inhibit platelet aggregation. The ability to fine-tune its structure allows medicinal chemists to tailor its pharmacological properties for specific therapeutic needs.

In conclusion, tert-butyl 3-chloropyrrolidine-1-carboxylate (CAS No. 1289386-88-4) represents a cornerstone intermediate in modern pharmaceutical synthesis. Its unique structural attributes make it an indispensable tool for drug discovery efforts aimed at treating a wide range of diseases. As research continues to uncover new applications and synthetic methodologies, this compound is poised to remain at the forefront of medicinal chemistry innovation.

• 210963-90-9(tert-butyl (2R)-2-(chloromethyl)pyrrolidine-1-carboxylate)
• 1187927-12-3(tert-butyl (3R)-3-(chloromethyl)pyrrolidine-1-carboxylate)
• 1289584-82-2(tert-butyl (3S)-3-chloropyrrolidine-1-carboxylate)
• 1289585-27-8((R)-3-CHLORO-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER)
• 1142400-61-0(tert-butyl 2-(chloromethyl)pyrrolidine-1-carboxylate)
• 154874-94-9(Tert-butyl 4-chloropiperidine-1-carboxylate)
• 876589-13-8(tert-butyl 3-(chloromethyl)pyrrolidine-1-carboxylate)
• 857637-44-6(Carbamic acid, [2-(3-chloro-1-pyrrolidinyl)ethyl]-, 1,1-dimethylethyl ester)
• 885275-01-4(1-Boc-3-chloro-piperidine)
• 403735-05-7(tert-butyl (2S)-2-(chloromethyl)pyrrolidine-1-carboxylate)